SEC Form 4 · accession 0001179110-17-009115
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura J Schumacher
Officer — Executive Vice President
Period of report
Jun 14, 2017
Accepted (ET)
Jun 15, 2017 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Jun 14, 2017 | M | 79,800 | $29.2265 | A | 187,625 | D | |
| Common stock, $0.01 par value | Jun 14, 2017 | S | 79,800 | $70.00 | D | 107,825 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy) | $29.2265 | Jun 14, 2017 | M | 79,800 | D | Feb 17, 2015 | Feb 16, 2022 | Common stock | 79,800 | 0 | D |
Remarks
This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).